INTRODUCTION
============

As it was formulated by Watson and Crick over 50 years ago, the standard nucleobase pair follows two rules of complementarity: size complementarity (large purines pair with small pyrimidines) and hydrogen bonding complementarity (hydrogen bond donors pair with hydrogen bond acceptors) ([@b1],[@b2]). Many groups have worked to deviate from this formula ([@b3]). For example, Rappaport ([@b4]), Ishikawa *et al*. ([@b5]),Fujiwara *et al*. ([@b6]), Hirao *et al*. ([@b7]) and Sismour *et al*. ([@b8]) have sought to change hydrogen-bonding patterns and to control the outcome with sulfur and/or steric interactions. Kool and his group have sought to dispense with hydrogen bonding entirely ([@b9],[@b10]), as have Romesberg, Schultz and their coworkers ([@b11],[@b12]) using hydrophobic interactions. In the opposite direction, Minakawa *et al*. have sought to increase the number of interpair hydrogen bonds ([@b13]).

Despite the success of this work, alternative nucleic acid-like systems that deviate less drastically from the standard design have had, to date, the technological success and supported best the emerging field of synthetic biology ([@b14]). If nitrogen and oxygen are used as the only heteroatoms, six different hydrogen-bonding patterns can be directly placed within the standard Watson--Crick geometry. Here, they support mutually exclusive nucleobase pairing in an 'artificially expanded genetic information system' (AEGIS) ([@b15]--[@b17]) ([Figure 1](#fig1){ref-type="fig"}).

Two AEGIS components built according to this design, 2′-deoxyisoguanosine and 2′-deoxyisocytosine, are now incorporated into Bayer\'s branched DNA diagnostics tools that quantitate the levels of human immunodeficiency, hepatitis B and hepatitis C viruses in blood. These help improve the health care of over 400 000 patients annually ([@b18],[@b19]). This pair also supports assays in development to detect certain genetic defects that cause cystic fibrosis ([@b20]). Further, using mutant polymerases that accept the non-standard nucleobases, and special strategies to manage undesired tautomerism of isoguanosine, AEGIS supports now two versions of the polymerase chain reaction that incorporate 6 nt 'letters' ([@b8],[@b21]). Thus, these versions of DNA can support a primitive form of evolution.

This and other work has uncovered certain structural features of the nucleobases that make different AEGIS components more or less likely to be accepted by natural DNA polymerases. Most important is the ability of the component to present an unshared pair of electrons (or, more formally, 'electron density') to the minor groove ([@b22]). In the standard purines, adenosine and guanosine, this density is presented by nitrogen 3 ([Figure 1](#fig1){ref-type="fig"}). In the standard pyrimidines, thymidine and cytidine, this density is presented by the exocyclic carbonyl oxygen at the 2-position ([@b23]).

Only one AEGIS hydrogen bonding pair (other than the standard A:T and G:C pairs) can present unshared electron pairs to the minor groove from both components. This is the pyDDA and puAAD pair, implemented on heterocycles where the purine analog has a nitrogen at the position analogous to N3 on standard purines, and the pyDDA component has an exocyclic carbonyl oxygen at the position analogous to the 2-position on standard pyrimidines.

The pyDDA hydrogen-bonding pattern has proven to be especially difficult to implement in a form that can support synthetic biology, however. Our first effort, implementing the pyDDA hydrogen bonding pattern on a pyridine heterocycle gave easily oxidized compounds ([@b24]). The pyrazine implementation of the pyDDA hydrogen bonding pattern was stable to oxidation, but suffered epimerization ([@b25],[@b26]). The pyDDA pattern implemented on a pyrimidine heterocycle would give rise to tautomeric ambiguity.

One promising solution to these problems exploits the nitro group to moderate the reactivity of the aminopyridone heterocycle. The electron withdrawing properties of the nitro group, attached to an aminopyridone 2′-deoxyriboside, were indeed found to diminish the oxidizability of the heterocycle, and decrease the rate of specific-acid catalyzed epimerization ([@b27]). This was shown in model studies using 6-amino-5-nitro-3-(1′-β-D-2′-deoxyribofuranosyl)-2(1H)-pyridone (here called d**Z)** ([@b27]).

The hydrogen bonding partner for d**Z** must implement the puAAD hydrogen-bonding pattern. The 2-amino-8-(2′-deoxy-β-D-erythro-pentofuranosyl)-imidazo\[1,2-a\]-1,3,5-triazin-4(8H)-one, referred to here as d**P**, has previously been proposed for this purpose ([@b28]). This *N*-glycoside is stable to epimerization, is rather stable to 'depurination' under acidic conditions, and has previously been studied as an antiviral agent ([@b29],[@b30]).

Here we present an improved synthesis of d**Z** and d**P** nucleosides. The d**Z** nucleoside is prepared by gram scale Heck-coupling of an oxygen-protected iodinated heterocycle and a suitable glycal ([@b31]), followed by reduction. We also describe the preparation of the protected phosphoramidites and triphosphates of d**Z** and d**P**. Both phosphoramidites were used to synthesize DNA oligonucleotides with good coupling efficiency. We verified that d**Z** remains stable against epimerization during the synthesis of the oligonucleotides. Finally, we report the hybridization properties of DNA oligonucleotides containing the d**Z**:d**P** nucleobase pair, and some data that demonstrate the ability of each nucleobase to discriminate against mismatches in short duplex DNA. These experiments suggest that the d**Z**:d**P** nucleobase pair contributes more to duplex stability than any of the standard nucleobase pairs.

MATERIALS AND METHODS
=====================

Nucleotide and oligonucleotide synthesis
----------------------------------------

Full experimental procedures describing the synthesis of the compounds used in this work are available in Supplementary Data.

RESULTS
=======

Synthesis of nucleoside phosphoramidite of dZ
---------------------------------------------

The synthesis of the *C*-nucleoside **1** (d**Z**) to implement the non-standard pyDDA hydrogen-bonding pattern was recently reported ([@b27]). This nucleoside was stable with respect to epimerization for hours, even at low pH (pH 3). When we attempted to synthesize the phosphoramidite starting with that fully deprotected nucleoside, however, we observed that the strong nucleophilicity of the heterocyclic keto group prevented a selective reaction during dimethoxytritylation; the DMT group went to the 2-position of the heterocycle as well as the 5′-position of the sugar ([Figure 2](#fig2){ref-type="fig"}). This nucleophilicity also caused problems during the preparation of the phosphoramidite ([@b32]).

To circumvent these problems, the published procedure was modified to protect the oxygen on the heterocycle prior to Heck coupling ([Figure 3](#fig3){ref-type="fig"}) using the *p*-nitrophenethyl (NPE) protecting group of Pfleiderer and co-workers ([@b33]). These *p*-NPE ethers are stable under acidic and mild hydrolytic conditions (e.g. ammonia and triethylamine), but are cleaved by DBU in aprotic solvents.

To obtain predominantly *O*-alkylation, heterocycle **4** was treated with 2-(4-nitrophenyl)-ethyl iodide and silver carbonate in benzene ([@b34],[@b35]). After optimization of the conditions, the yield was only about 40%. Since the p*K*~a~ of heterocycle **4** (≈7.8) meets the requirement of a p*K*~a~ \< 13 for a Mitsunobu reaction, we investigated this reaction as a way of achieving *O*-alkylation ([@b36]--[@b38]). NPE protection at *O*^2^ was achieved in over 90% yield by treatment of **4** with 4-NPE alcohol ([@b5]) under Mitsunobu conditions ([@b39]). Protection of the exocyclic amino group of **6** as the diisobutylformamidine to give **7** occurred again in low yield, perhaps due to instability of the product during flash column purification ([@b40],[@b41]). The amino group was therefore benzoylated to give monobenzoate **8** in over 70% yield after mild hydrolysis of the dibenzoate that was formed initially ([@b42],[@b43]).

Heck couplings of iodinated heterocycles to the glycal **9** and subsequent deprotection and reduction, have been reported previously by several groups for several *C*-glycosides ([@b44]--[@b46]), and have been used in our previous synthesis of d**Z** ([@b27]). The use of the *tert*-butyldiphenylsilyl protecting group at the 3′-position blocks one side of the sugar glycal so that the Heck coupling occurs exclusively from the 'top' to give the β-*C*-nucleoside ([Figure 3](#fig3){ref-type="fig"}). The free 5′-hydroxyl of the sugar then leads to stereospecific reduction of the intermediate ketone by complexation with the boron.

Following literature procedures, palladium acetate and triphenylarsine were used as the catalyst system, with anhydrous DMF as the solvent. The Heck reaction was run at 55°C for three days. The desilylated 2′-deoxy-3′-keto-β-*C*-nucleoside **10** was isolated as the only product, in 20% yield, and the major byproduct was the deiodination of the heterocycle. This was presumably generated via the reaction of iodide to desilylate the silyl enol ether derivative during the coupling reaction ([@b47],[@b48]). Reduction of the ketone with triacetoxyborohydride yielded the 2′-deoxy-β-*C*-nucleoside **11** in quantitative yield.

The low yield of the Heck coupling was ascribed to the electron withdrawing benzoyl group, which renders the heterocycle electron-poor. Therefore, the Heck coupling between non-benzoylated heterocycle **6** and glycal **9** was explored. After 3 days at 55°C, β-*C*-nucleosides **12** and **13** were obtained in 31 and 39% yield, respectively. As with **10**, the 2′-deoxy-3′-keto-β-*C*-nucleoside **13** was generated *in situ* from desilylation of intermediate **12**. Rapid removal of the silyl protecting group of **12** with TBAF at 0°C gave ketone **13**. Reduction of the ketone with triacetoxyborohydride gave the 2′-deoxy-β-*C*-nucleoside **14**. Perbenzoylation of **14** with benzoyl chloride gave **15**, which was selectively deprotected with 1 M aqueous NaOH to give monobenzoate **11** in 80% overall yield. Two more steps led to the 5′-DMT protected phosphoramidite derivative **17**, ready for solid-phase DNA synthesis.

To test the suitability of NPE as a protecting group in oligonucleotide synthesis, the NPE of **14** was removed by DBU (1 M in CH~3~CN) to give 2′-deoxy-β-*C*-nucleoside **1** (d**Z**) in 95% yield after flash chromatography ([Figure 3](#fig3){ref-type="fig"}). The ^1^H-NMR, ^13^C-NMR and high-performance liquid chromatography (HPLC) trace were the same as reported in literature for **1** ([@b27]).

Synthesis of the nucleoside 5′-triphosphate of dZ
-------------------------------------------------

According to the classical procedure developed by Ludwig and Eckstein ([@b49]), the protection of functional groups on the standard nucleobase heterocycles is not required during the synthesis of the corresponding 5′-triphosphates. Thus, we began the synthesis of the d**Z** triphosphate without protecting the heterocycle by selectively protecting the 5′-OH of nucleoside **14** with DMT-Cl to give **18** in 80% yield. Selective acetylation to give the 3′-acetate **19** with excess Ac~2~O (10 equivalent) in pyridine at room temperature was accomplished in nearly quantitative yield after column chromatography. Surprisingly, the exocyclic amino group did not react with either DMT-Cl or Ac~2~O under these particular reaction conditions.

The 5′-DMT protecting group was removed by saturated methanolic HCl to give **20** in 90% yields. The nucleoside 5′-triphosphate **21** was prepared by the 'Ludwig--Eckstein procedure' ([@b49]). The NPE group was then removed by treatment with DBU (0.8 M in acetonitrile) at room temperature for 4 h. Subsequent treatment with concentrated ammonium hydroxide at room temperature furnished the fully deprotected 5′-triphosphate **22** (d**Z**TP) in 10% overall yield after HPLC purification on DEAE-Sephadex and C-18 ([Figure 4](#fig4){ref-type="fig"}).

Synthesis of the phosphoramidite and 5′-triphosphate of dP
----------------------------------------------------------

The synthesis of **26**, the phosphoramidite of d**P**, followed the procedure developed by Seela and co-workers ([@b28]) with minor modifications ([Figure 5](#fig5){ref-type="fig"}). Seela\'s procedure calls for a delicate chromatographic resolution of the epimeric mixture obtained after attaching the heterocycle to the sugar, separating two compounds that have only slight differences in their *R*~f~ values. We found that adding the formamidine protecting group before the resolution of the epimers greatly improved the isolation of the pure β-epimer **24**.

The corresponding 5′-triphosphate **29** (d**P**TP) was synthesized as described in [Figure 5](#fig5){ref-type="fig"}, applying the Ludwig--Eckstein procedure. Although an enzymatic study using this triphosphate has been reported in literature ([@b50]), a full experimental procedure yielding the triphosphate has never, to our knowledge, been published.

Oligonucleotide synthesis
-------------------------

Oligonucleotides containing the AEGIS components were prepared by using the standard conditions, except that an extended coupling time (6 min) was used for the nonstandard nucleoside phosphoramidites. Based on the amount of DMT released, the coupling efficiency of the d**Z** and d**P** phosphoramidites was found to be similar to that obtained with commercial phosphoramidites of the standard nucleosides. The oligonucleotides containing d**P** were deprotected in concentrated ammonium hydroxide (60°C, 12 h). The products containing d**Z** were first treated with DBU (1 M in acetonitrile, 10 h, rt) prior to ammonium hydroxide deprotection ([@b51]). The crude oligonucleotides were purified by ion-exchange HPLC (Dionex DNAPac™ PA-100 column, 9 × 250 mm) and desalted over SepPak C~18~-cartridges. The homogeneity of the purified chimeras was verified by analytical ion-exchange HPLC. Their composition was determined by tandem digestion with snake-venom phosphodiesterase (SVPDE) I and alkaline phosphatase, followed by reverse-phase HPLC (Nova-Pak C~18~ column 3.9 × 150 mm) ([@b52]). The analyses in all cases verified the incorporation of the correct number of nonstandard nucleosides ([Table 1](#tbl1){ref-type="table"}).

Epimerization of dZ
-------------------

To estimate the extent of epimerization of d**Z** within an oligonucleotide during its synthesis and storage, a sample (4 nmol) of the oligonucleotide d(TGTG**Z**TGAAAGAGG) containing a single d**Z** was dissolved in TEAA \[25 mM (pH 7.0), 100 μl\] and divided into two aliquots. One was stored at −20°C; the other was kept at room temperature for two months. Both samples were then digested with snake-venom phosphodiesterase (SVPDE) I and alkaline phosphatase (Supplementary Data) and analyzed by reversed phase HPLC. The HPLC trace showed only the β-nucleoside peak for both samples, indicating that the nucleotide d**Z** entered the DNA as only the beta epimer, and is stable with respect to epimerization at neutral pH for months once incorporated into DNA

Thermal denaturation studies
----------------------------

To determine the contribution of the d**Z**:d**P** nucleobase pair to the stability of duplex DNA, thermal denaturation conditions reported by Geyer *et al*. and Horn *et al*. were applied ([@b17],[@b53]) (Supplementary Data). For comparison with their data, analogous oligonucleotides were used (Sequence pair 3). The variable position in the DNA duplex, denoted **X**:**Y**, was placed at least 4 nt from the end of the duplex, so as to eliminate 'end effects' ([@b54]). All experiments generated standard, single-transition melting, consistent with two-state melting behavior. This was expected, as the oligonucleotides are not able to form significant alternative duplex or hairpin structures.

The melting temperatures for DNA duplexes were measured at pH 6.3, 7.0 and 7.9 ([Table 2](#tbl2){ref-type="table"}). These pH values were chosen both to enable a comparison with literature data, and to reflect the known p*K*~a~ of the d**Z** heterocycle; the d**P** does not have an acidic hydrogen within this range, and the triazene skeleton is only very weakly basic. At pH 6.3, protonation of d**Z** is complete, while the standard nucleobases are only slightly protonated.

The data in [Table 2](#tbl2){ref-type="table"} indicate that a d**Z**:d**P** nucleobase pair is significantly stronger than a d**C**:d**G** base pair, increasing the *T*~m~ on the average by 1.8°C per pair at pH 6.3 and 7.0. The effect of two consecutive d**Z**:d**P** nucleobase pairs in the same oligomer is more than additive, with an increase in *T*~m~ of 2.8°C per pair at pH 7.0. Consistent with the acidity of d**Z**, the contribution of the d**Z**:d**P** nucleobase pair is less at pH 7.9.

DISCUSSION
==========

These results establish that 6-amino-5-nitro-3-(1′-β-D-2′-deoxyribofuranosyl)-2(1H)-pyridone (d**Z**) and 2-amino-8-(1′-β-D-2′-deoxyribofuranosyl)-imidazo\[1,2-a\]-1,3,5-triazin-4(8H)-one (d**P**) implement the pyDDA and puAAD hydrogen bonding patterns as part of an AEGIS. The properties of both heterocycles allow them to be practically useful. Indeed, the d**Z**:d**P** nucleobase pair appears, in the studies done so far, to contribute more than the dG:dC nucleobase pair to duplex stability. In this respect, it is similar to the nucleobase pair between isoguanosine and isocytidine (puDDA and pyAAD, respectively). The Δ*T*~m~ values of the d**Z**:d**P** and diso^Me^C:disoG nucleobase pairs are 1.8° and 2.0°C per nucleobase pair, respectively (relative to the C:G pair).

The d**Z**:d**P** nucleobase pair does not present the chemical problems that the diso^Me^C:disoG nucleobase pair presents, however, including tautomerization, depyrimidinylation (of isoC) and deamination ([@b55]). Further, both components of the d**Z**:d**P** nucleobase pair present unshared pairs of electrons to the minor groove. As noted in the Introduction, these are specificity elements for many polymerases at many points in the primer--template--triphosphate complex.

The stability of the d**Z**:d**P** nucleobase pair depends on pH, just as do the standard dA:dT and dG:dC nucleobase pairs. The heterocycle on the d**Z** nucleoside is an acid with a p*K*~a~ value of ca. 7.8 (in the free nucleoside form). When deprotonated, the H-bonding pattern is changed. Further, Geyer *et al*. ([@b17]) showed that the introduction of a negative charge into a stack of nucleobases decreases the stability of the duplex. These are both consistent with the observed reduction in *T*~m~ for duplexes joined by the d**Z**:d**P** nucleobase pair at pH 7.9.

The data also show the high specificity of the d**Z**:d**P** nucleobase pair. In the limited studies that we have done so far, nucleobase combinations other than those having complementary pairing lead to reductions in *T*~m~ similar to those seen in mismatches between the standard nucleobases. This allows both of the non-standard nucleobases, d**Z** and d**P**, to discriminate against mismatches in short duplex DNA, at least in the contexts examined so far.

Last, the synthesis of the triphosphates of the nucleosides d**Z** and d**P** is reported. These syntheses support ongoing work investing the ability of DNA polymerases to copy DNA containing the d**Z**:d**P** nucleobase pair. Results from these investigations will be reported shortly.
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![The AEGIS that follows closely the geometry and hydrogen bonding architecture of natural nucleotides ([@b1],[@b2]). The various hydrogen bonding patterns are named pu or py, depending on whether they are presented on a large (purine-like) or small (pyrimidine-like) heterocyclic ring system, with hydrogen bond donor (D) and acceptor (A) groups listed starting in the major groove and ending in the minor groove. Unshared pairs of electrons (or 'electron density') presented to the minor groove are shown by the shaded lobes. The pyDDA:puAAD hydrogen bonding pattern, the subject of this paper, is at the bottom right.](gkl633f1){#fig1}

![Conditions: (a) N, N-Diisobutylformamide dimethyl acetal, MeOH, rt; (b) (MeO)~2~TrCl, Py, Et~3~N, DMAP, 0°C to rt.](gkl633f2){#fig2}

![Conditions: (a) DEAD, Ph~3~P, dioxane/DMF (4/1, v/v), 0°C to rt, 92%; (b) N, N-Diisobutyl formamide dimethyl acetal, MeOH, rt; (c) i) BzCl, DMAP, Py, Et~3~N, 0°C to rt; ii) H~2~O, NH~4~OH (29%), 0°C, 73% (over two steps); (d) Pd(OAc)~2~, Ph~3~As, Et~3~N, DMF, 55°C; (e) NaBH(OAc)~3~, AcOH, CH~3~CN, 0°C, 98%; (f) Bu~4~NF, AcOH, THF, 0°C, 90%; (g) BzCl, DMAP, Py, Et~3~N, rt, 85%; (h) 1 M NaOH / H~2~O, 1,4-dioxane, rt, 90%; (i) (MeO)~2~TrCl, Py, Et~3~N, rt, 80%; (j) iPr~2~N(OC~2~H~4~CN)PCl, DIPEA, CH~2~Cl~2~, 0°C to rt, 71%.](gkl633f3){#fig3}

![Conditions: (a) (MeO)~2~TrCl, Py, Et~3~N, rt, 80%; (b) Ac~2~O, Py, rt, 94%; (c) HCl, MeOH, CH~2~Cl~2~, 0°C, 90%; (d) i) 2-Chloro-4*H*-1,3,2-benzodioxaphosphorin-4-one, Py, dioxane, rt; ii) tributylammonium pyrophosphate, n-Bu~3~N, DMF, rt; iii) I~2~, H~2~O, Py, rt; (e) i) DBU, CH~3~CN, rt; ii) H~2~O, NH~4~OH, rt, 10% (over two steps).](gkl633f4){#fig4}

![Conditions: (a) Dibutylformamide dimethyl acetal, MeOH, 40°C, β isomer 53%, α isomer 37%; (b) (MeO)~2~TrCl, Py, Et~3~N, rt, 75%; (c) iPr~2~N(OC~2~H~4~CN)PCl, DIPEA, CH~2~Cl~2~, 0°C to rt, 76% ; (d) Ac~2~O, Py, rt, 93%; (e) HCl, MeOH, CH~2~Cl~2~, 0°C, 99%; (f) i) 2-Chloro-4*H*-1,3,2-benzodioxaphosphorin-4-one, Py, dioxane, rt; ii) tributylammonium pyrophosphate, n-Bu~3~N, DMF, rt; iii) I~2~, H~2~O, Py, rt; iv) H~2~O, NH~4~OH, 45°C, 20% (over two steps).](gkl633f5){#fig5}

###### 

Analysis of the oligonucleotides by enzymatic digestion[a](#tf1-1){ref-type="table-fn"}

                              Calculated   Found                                       
  --------------------------- ------------ ------- --- --- --- ----- ----- ----- ----- -----
  3′-TGTG**Z**TGAAAGAGG-5′    0            6       3   4   1   0.0   6.1   3.0   4.0   0.9
  5′-CAC**P**ACTTTCTCCT-3′    6            0       5   2   1   6.0   0.0   5.0   2.0   1.1
  3′-CAGTTCAC**Z**GATTGC-5′   4            3       4   3   1   4.0   3.0   3.9   2.9   0.9
  5′-GTCAAGTG**P**CTAACG-3′   3            4       3   4   1   3.0   4.0   3.0   3.9   1.1
  3′-CAGTTCAC**ZZ**ATTGC-5′   4            2       4   3   2   4.0   2.0   4.0   3.0   1.8
  5′-GTCAAGTG**PP**TAACG-3′   2            4       3   4   2   2.0   4.0   3.0   3.9   2.2

^a^Conditions: oligonucleotide 1.5 nmol, SVPDE 6 × 10^−3^ U, alkaline phosphatase 1.5 U, Digestion buffer \[0.1 M Tris--HCl (pH 8.3) and 20 mM MgCl~2~\], followed by reversed phase HPLC.

###### 

Melting temperature (°C) for nucleobase pairs in selected oligonucleotides[a](#tf2-1){ref-type="table-fn"},[b](#tf2-2){ref-type="table-fn"}

![](gkl633t1)

^a^Conditions: 1.6 μM DNA strand concentration, 0.5 M NaCl at pH 6.3 and 7.0 (5 mM phosphate buffer), 0.05 mM EDTA; 0.45 M NaCl, 45 mM sodium citrate (pH 7.9).

^b^Conditions: sequence pair 3, as reported by Geyer and Horn ([@b17],[@b53]). 1.6 μM DNA strand concentration, 0.45 M NaCl, 45 mM sodium citrate, pH 7.9.

^c^Data of columns 1, 2 and 3 are from Sequence pair 1.

^d^Sequence pair 2, two consecutive Z/P base pairs in the same oligomer, Δ*T*~m~ indicate the *T*~m~ difference of per base pair compare to C/G base pair.

^e^Data of columns 5 and 6 are from Sequence pair 3.

^f^The *T*~m~ reported by Geyer and Horn ([@b17],[@b53]).
